LMNA and small cell lung carcinoma: In this review, using the examples of SCLC and HGPS, we focused specifically on small molecules that inhibit protein–protein interactions (PPIs) by interacting directly with one protein partner from a splicing variant, rather than binding at functional sites of the other partners.